Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT®) trial is a Randomized Controlled Clinical Trial that aims to identify treatments of COVID-19 Infection through Hydroxychloroquine, Oseltamivir and Azithromycin .
Trial Intro
Prof. Javed Akram
Vice Chancellor, University of Health Sciences & Principal Investigator
Several experts foresaw the emergence of zoonotic viruses like SARS-CoV-2 (COVID-19) following SARS-1 and MERS-CoV within last two decades. They owed it to the underlying burden of expanding human populations that encroach upon traditional habitats and ecosystems in the backdrop of ongoing climate disruption, one of the most formidable challenges to lifestyles and economies. Going by the observation, SARS-CoV-2 may not be the last pandemic to inflict long lasting damage with no reliable treatment available. The race is on to develop complementing diagnostic and treatment strategies to control the spread of this zoonotic virus. Along the way, myths and scandals have been chronicled. Antimalarial and ant-arthritic drug Hydroxychloroquine would probably feature in every historic reference to the ongoing pandemic. Billed as miracle drug by some while quickly debunked by many others, it could well be the most self-prescribed drug for SARS-CoV-2.
